#RandomizedTrial
A new randomized controlled trial (Lak et al., JISSN 2025) found NO evidence that standard-dose creatine monohydrate causes hair loss in 38 resistance-trained men. The my…

#Creatine #Hairloss #Randomizedtrial #Sportsnutrition #Supplementsafety

#Creatine #Hairloss #Randomizedtrial #Sportsnutriti…
Creatine Hair Loss Myth Debunked by RCT
A new randomized controlled trial (Lak et al., JISSN 2025) found NO evidence that standard-dose creatine monohydrate causes hair loss in 38 resistance-trained men. The my… #Creatine #Hairloss #Randomizedtrial #Sportsnutrition #Supplementsafety
news.gmj.ge
October 28, 2026 at 7:26 PM
AROA Trial Finds Higher Diabetic Foot Ulcer Closure With Symphony AROA reported statistically significant gains in diabetic-foot-ulcer...

https://www.narrowit.com/news/aroa-symphony-diabetic-foot-ulcer-randomized-trial-2026-10-05
#AroaBiosurgery #Symphony #DiabeticFootUlcers #RandomizedTrial
AROA Symphony Trial Reports Higher Diabetic Foot Ulcer Closure | Narrowit.com
A 143-patient randomized trial found higher 12-week ulcer closure and faster healing with AROA's Symphony plus standard care.
www.narrowit.com
October 5, 2026 at 10:40 AM
JMIR Formative Res: Automated Feedback After Internet-Based Depression Screening: Cost-Effectiveness Analysis of a Randomized Controlled Trial #MentalHealth #DepressionScreening #AutomatedFeedback #CostEffectiveness #RandomizedTrial
Automated Feedback After Internet-Based Depression Screening: Cost-Effectiveness Analysis of a Randomized Controlled Trial
Background: The clinical and cost-related consequences of internet-based depression screening, in combination with automated feedback, have been rarely investigated. We aimed to conduct a cost-effectiveness analysis (CEA) of DISCOVER, a three-armed, observer-masked, randomized controlled trial that focused on two versions of automated feedback interventions after internet-based depression screening. Objective: This study aims to evaluate the cost-effectiveness of automated non-tailored and tailored feedback interventions, after internet-based depression screening, from a societal perspective. Methods: Participants were recruited from the general population via traditional and social media. Participants who were undiagnosed but screened positive for depression on an online version of the Patient Health Questionnaire-9 (PHQ-9; ≥10 points) were randomized to automatically receive either no feedback, non-tailored feedback, or tailored feedback. The feedback interventions included the depression screening result, a recommendation to seek professional advice, and brief general information about depression. The tailored feedback was additionally framed as per the participants’ symptom profiles, treatment preferences, as well as health insurance plan, and local residency. The time horizon was six months. The main outcome was the incremental cost-effectiveness ratio (ICER) from a societal perspective using quality-adjusted life-years (QALY) based on the EQ-5D-5L. Cost-effectiveness acceptability curves (CEAC) were constructed. Furthermore, several sensitivity analyses and explorative subgroup analyses were conducted. Results: 1,012 participants (no feedback: 343; non-tailored feedback: 338; tailored feedback: 331) were included. Differences in costs and effects were not statistically significant. Still, ICER results indicated that both no feedback and tailored feedback exhibited dominance over non-tailored feedback. The ICER of tailored feedback compared to no feedback was €109,730/QALY, whereas both costs and QALYs were lower in tailored feedback. The cost-effectiveness probability of tailored feedback compared to no feedback ranged between 41% and 80%. Sensitivity analyses exhibited similar trends. Conclusions: Six months post-intervention, feedback interventions had no statistically significant effect on costs from a societal perspective nor on QALYs. Tailored feedback was associated with moderate cost-effectiveness probabilities compared to no feedback. Explorative subgroup analyses revealed subpopulations for which the interventions might be cost-effective. Clinical Trial: ClinicalTrials.gov: NCT04633096
dlvr.it
December 23, 2025 at 4:39 PM
Key point: A low dose of antiseizure medications may be started in adults with a new diagnosis of focal epilepsy of unknown etiology and low seizure frequency.
doi.org/10.1002/epi4...

#epilepsy #ILAE #efficacy #focalepilepsy #lowdose #monotherapy #newlydiagnosedepilepsy #randomizedtrial
March 4, 2025 at 3:36 PM
🏥 Major breakthrough: Tranexamic acid reduces surgical bleeding by 30% in landmark international trial. 9,535 patients across 29 countries showed c…

#NEJM #Perioperativecare #Randomizedtrial #Surgicalbleeding #Tranexamicacid

#NEJM #Perioperativecare #Randomizedtrial #Surgicalbleeding #Tranexami…
Surgery Drug Cuts Bleeding by 30% in Major Trial
🏥 Major breakthrough: Tranexamic acid reduces surgical bleeding by 30% in landmark international trial. 9,535 patients across 29 countries showed c… #NEJM #Perioperativecare #Randomizedtrial #Surgicalbleeding #Tranexamicacid
news.gmj.ge
July 3, 2026 at 4:43 AM
Efficacy of nebulised versus intravenous tranexamic acid in management of non-massive haemoptysis: A randomised controlled trial.
Dinesh, Vasudha et al.
Paper
Details
#Hemoptysis #TranexamicAcid #RandomizedTrial
January 1, 2026 at 9:02 AM
Optimizing the integration of #RandomizedTrial #RCT and observational studies of interventions in #SystematicReviews and health #guidelines can be challenging. This #GRADE guidance tells you how.

pubmed.ncbi.nlm.nih.gov/34800676/
GRADE guidance 24 optimizing the integration of randomized and non-randomized studies of interventions in evidence syntheses and health guidelines - PubMed
This work aims to help methodologists in review teams, technology assessors, guideline panelists, and anyone conducting evidence syntheses using GRADE.
pubmed.ncbi.nlm.nih.gov
June 14, 2026 at 3:08 PM
Compelling evidence from a #RandomizedTrial (RCT) looking at #PatientImportantOutcomes (PROMS): 7-point scales and #VisualAnalogueScales (VAS) show similar validity and responsiveness (sensitivity to change) to detect intervention effects. Either choice is fine.

pubmed.ncbi.nlm.nih.gov/2157581/
A comparison of seven-point and visual analogue scales. Data from a randomized trial - PubMed
Many controlled trials rely on subjective measures of symptoms or quality of life as primary outcomes. The relative merits of different response options for these instruments is an important issue. Therefore, we compared the responsiveness and validity of seven-point versus visual analogue scales (V …
pubmed.ncbi.nlm.nih.gov
March 2, 2026 at 4:03 AM
Just published big news for #IntensiveCare. #RandomizedTrial demonstrates that a #ProtonPumpInhibitor not only decreases gastrointestinal #bleeding, but because of #costs generated by those bleeds also appreciably decreases #ICU costs.

jamanetwork.com/journals/jam...
Cost-Effectiveness of Pantoprazole for Upper GI Bleeding During Ventilation
This economic evaluation examines cost-effectiveness of daily intravenous pantoprazole vs no pantoprazole for preventing upper gastrointestinal bleeding in critically ill, mechanically ventilated pati...
jamanetwork.com
December 15, 2025 at 1:58 AM
Anyone interested in determining the effect of a drug in a single patient by conducting a #RandomizedTrial in a that patient – an N of 1 trial – will find this step-by-step guide enormously useful.

www.cmaj.ca/content/139/...
A clinician's guide for conducting randomized trials in individual patients
In determining optimal treatment for a patient conventional trials of therapy are susceptible to bias. Large-scale randomized trials can provide only a partial guide and have not been or cannot be car...
www.cmaj.ca
November 6, 2025 at 11:57 AM
The ground-breaking #NEJM #randomizedTrial suggests that every #surgery patient at substantial #bleeding risk should receive #tranexamicAcid: 24% #RelativeRisk reduction in serious bleeding.

www.nejm.org/doi/full/10....
Tranexamic Acid in Patients Undergoing Noncardiac Surgery | NEJM
Perioperative bleeding is common in patients undergoing noncardiac surgery. Tranexamic acid is an antifibrinolytic drug that may safely decrease such bleeding. We conducted a trial involving patien...
www.nejm.org
October 28, 2025 at 5:19 AM